Application 020538
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ESTRADIOL | ESTRADIOL | Film, Extended Release; Transdermal | 0.0375MG/24HR | No | No |
| 002 | ESTRADIOL | ESTRADIOL | Film, Extended Release; Transdermal | 0.075MG/24HR | No | No |
| 003 | ESTRADIOL | ESTRADIOL | Film, Extended Release; Transdermal | 0.05MG/24HR | No | No |
| 004 | ESTRADIOL | ESTRADIOL | Film, Extended Release; Transdermal | 0.1MG/24HR | No | No |
| 005 | VIVELLE-DOT | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.0375MG/24HR | Yes | No |
| 006 | VIVELLE-DOT | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.05MG/24HR | Yes | No |
| 007 | VIVELLE-DOT | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.075MG/24HR | Yes | No |
| 008 | VIVELLE-DOT | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.1MG/24HR | Yes | Yes |
| 009 | VIVELLE-DOT | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.025MG/24HR | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020538-005 | VIVELLE-DOT | ESTRADIOL | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 |
| N020538-006 | VIVELLE-DOT | ESTRADIOL | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 |
| N020538-007 | VIVELLE-DOT | ESTRADIOL | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 |
| N020538-008 | VIVELLE-DOT | ESTRADIOL | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 |
| N020538-009 | VIVELLE-DOT | ESTRADIOL | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020538-005 | AB1 |
| N020538-006 | AB1 |
| N020538-007 | AB1 |
| N020538-008 | AB1 |
| N020538-009 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | b8a1b40f171c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N020538-005 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-006 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-007 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-008 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-009 | AB1 | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-005 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-006 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-007 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-008 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-009 | AB1 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-005 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-006 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-007 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-008 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-009 | AB1 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-005 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-006 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-007 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-008 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-009 | AB1 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-005 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-006 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-007 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-008 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-009 | AB1 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-005 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-006 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-007 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-008 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-009 | AB1 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-005 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-006 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-007 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-008 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-009 | AB1 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-005 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-006 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-007 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-008 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-009 | AB1 | 1 | b8a1b40f171c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Estradiol | ESTRADIOL | A-S Medication Solutions | c8a2d29c-299c-4559-b859-87b303a4af81 | 2026-08-28 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol | ESTRADIOL | Trigen Laboratories, LLC | e84ad638-6768-41aa-b2b8-e2514ef63881 | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| ESTRADIOL VAGINAL | ESTRADIOL | Redpharm Drug | 58beabb8-6902-b26a-e063-6294a90a67f8 | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Minivelle | ESTRADIOL | Noven Therapeutics, LLC | 6c5c47ab-28ee-11e1-bfc2-0800200c9a66 | 2026-07-31 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | Redpharm Drug | 5718f042-e8c0-b721-e063-6294a90a5bef | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| ESTRADIOL | ESTRADIOL | A-S Medication Solutions | 5c9a2e0f-704b-4d16-8ea3-d94f7f36ce6b | 2026-07-01 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL ESTRADIOL |
| Estradiol | ESTRADIOL | ANI Pharmaceuticals, Inc. | ff28c624-906d-459c-8b8c-27cb1a664e12 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol Vaginal | ESTRADIOL | Redpharm Drug | 546c168d-2a85-69b6-e063-6294a90a22ac | 2026-06-17 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| ESTRADIOL | ESTRADIOL | Bryant Ranch Prepack | e6bf2abc-71ae-4e79-a37b-164c98ba746a | 2026-06-16 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL ESTRADIOL |
| Estradiol | ESTRADIOL | A-S Medication Solutions | 34bcec8e-c7a6-4a1c-9884-4d4efe024bb9 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol | ESTRADIOL | REMEDYREPACK INC. | 41f7a56c-4ce3-4cc6-803e-1ff662efef90 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol | ESTRADIOL | REMEDYREPACK INC. | 59a4b68d-a507-4809-a0c8-fd9799986d12 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol | ESTRADIOL | A-S Medication Solutions | ba935918-39b3-4b56-bd83-78a29958e6d8 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol | ESTRADIOL | A-S Medication Solutions | 1c38f0d0-a360-4b66-bc0e-7d54e92465a1 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol | ESTRADIOL | A-S Medication Solutions | eacafc4a-2fa8-403d-8df7-2bc92d73a54f | 2026-06-03 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol | ESTRADIOL | A-S Medication Solutions | ee5460ab-27e7-487a-a89c-bf8735399be6 | 2026-06-03 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estradiol | ESTRADIOL | REMEDYREPACK INC. | 774ee81b-8e29-46af-ab12-7157f63b443b | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| EstroGel | ESTRADIOL | ASCEND Therapeutics US, LLC | 762ac371-bb8b-47e7-b48f-e80d452c9dd4 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| ESTRADIOL | ESTRADIOL | A-S Medication Solutions | afd70875-0a93-40a7-842e-f4359818c2d9 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL ESTRADIOL |
| Estradiol | ESTRADIOL GEL 0.1% | Xiromed, LLC | 1a46efe6-21b9-3f0f-90b9-59f279ef51df | 2026-05-18 | Boxed warning, Warnings, Adverse reactions | Estradiol |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0078-0343 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0343 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0343 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0343 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0343 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0344 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0344 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0344 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0344 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0344 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0345 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0345 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0345 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0345 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0345 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0346 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0346 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0346 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0346 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0346 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0365 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0365 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0365 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0365 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0365 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0781-7129 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7129 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7129 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7129 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7129 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7138 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7138 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7138 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7138 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7138 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7144 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7144 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7144 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7144 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7144 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7156 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7156 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7156 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7156 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7156 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7167 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7167 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7167 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7167 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7167 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 68071-3326 | Estradiol | estradiol | NuCare Pharmaceuticals,Inc. | NDA AUTHORIZED GENERIC | Current |
| 68071-3326 | Estradiol | estradiol | NuCare Pharmaceuticals,Inc. | NDA AUTHORIZED GENERIC | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 77569 | SUPPL | 2024-02-20 |
| 77546 | SUPPL | 2024-02-16 |
| 69008 | SUPPL | 2021-10-15 |
| 68886 | SUPPL | 2021-10-05 |
| 68885 | SUPPL | 2021-10-05 |
| 68874 | SUPPL | 2021-10-05 |
| 68873 | SUPPL | 2021-10-05 |
| 68541 | SUPPL | 2021-09-03 |
| 50287 | SUPPL | 2017-11-03 |
| 12696 | SUPPL | 2014-08-01 |
| 2687 | SUPPL | 2014-08-01 |
| 34795 | SUPPL | 2013-05-21 |
| 34794 | SUPPL | 2013-05-21 |
| 25134 | SUPPL | 2013-05-21 |
| 25133 | SUPPL | 2013-05-21 |
| 12695 | SUPPL | 2013-05-21 |
| 2686 | SUPPL | 2013-05-21 |
| 41418 | SUPPL | 2006-05-16 |
| 25132 | SUPPL | 2004-08-10 |
| 12694 | SUPPL | 2004-08-10 |
| 12693 | SUPPL | 2004-02-03 |
| 25131 | SUPPL | 2004-02-02 |
| 34793 | SUPPL | 2002-05-03 |
| 34792 | SUPPL | 2002-05-03 |
| 34791 | SUPPL | 2002-05-03 |
| 2685 | SUPPL | 2002-05-03 |
| 2684 | SUPPL | 2002-05-03 |
| 2683 | SUPPL | 2002-05-03 |
| 20708 | SUPPL | 1999-01-08 |
| 12692 | SUPPL | 1999-01-08 |
| 2682 | SUPPL | 1999-01-08 |